View Older Stories View More Recent Stories

Jun 6, 2023 10:00AM Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
Jun 1, 2023 10:00AM Phase 3 Studies of Pfizer’s Novel Antibiotic Combination Offer New Treatment Hope for Patients with Multidrug-Resistant Infections and Limited Treatment Options
Jun 1, 2023 05:47AM Pfizer (PFE) Announces FDA Approval of ABRYSVO for RSV in Older Adults
May 31, 2023 05:49PM U.S. FDA Approves ABRYSVO™, Pfizer’s Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Older Adults
May 30, 2023 03:22PM Seagen (SGEN) Stockholders Approve Acquisition by Pfizer (PFE)
May 30, 2023 06:50AM Pfizer (PFE) announces Phase 3 BASIS clinical trial for marstacimab has met its primary endpoints
May 30, 2023 06:45AM Pfizer Announces Positive Marstacimab Results from Pivotal Phase 3 Hemophilia A and B Trial
May 25, 2023 05:00PM Pfizer Presents Scientific Advancements from its Leading Oncology Portfolio at ASCO 2023 Annual Meeting
May 25, 2023 11:21AM Pfizer's (PFE) PAXLOVID Receives FDA Approval for Adult Patients at High Risk of Progression to Severe COVID-19
May 25, 2023 11:21AM Pfizer’s PAXLOVID™ Receives FDA Approval for Adult Patients at High Risk of Progression to Severe COVID-19
May 18, 2023 04:59PM Pfizer (PFE) Reports AdCom Vote in Support of Approval for Pfizer’s Vaccine Candidate to Help Prevent RSV in Infants Through Maternal Immunization
May 18, 2023 04:59PM FDA Advisory Committee Votes in Support of Approval for Pfizer’s Vaccine Candidate to Help Prevent RSV in Infants Through Maternal Immunization
May 15, 2023 07:52AM Pfizer (PFE) Announces Proposed Notes Offering
May 15, 2023 07:52AM  Pfizer Announces Proposed Notes Offering
May 8, 2023 07:00AM Arvinas and Pfizer Announce Upcoming Vepdegestrant (ARV-471) Poster Presentations at the 2023 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress
Apr 27, 2023 04:09PM Pfizer (PFE) Announces U.S. FDA Approves PREVNAR 20, its 20-valent Pneumococcal Conjugate Vaccine for Infants and Children
Apr 27, 2023 03:42PM U.S. FDA Approves PREVNAR 20®, Pfizer’s 20-valent Pneumococcal Conjugate Vaccine for Infants and Children
Apr 26, 2023 04:30PM Pfizer Declares Second-Quarter 2023 Dividend
Apr 13, 2023 10:00AM Pfizer Invites Shareholders to Attend Virtual-Only 2023 Annual Meeting of Shareholders on April 27
Apr 4, 2023 06:46AM Pfizer (PFE) announced FDA accepts sNDA for BRAFTOVI + MEKTOVI
Apr 4, 2023 06:45AM FDA Accepts Pfizer’s Supplemental New Drug Applications for BRAFTOVI + MEKTOVI
Mar 21, 2023 10:00AM Pfizer Invites Public to View and Listen to Webcast of May 2 Conference Call with Analysts
Mar 16, 2023 03:18PM Pfizer (PFE) Confirms FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for Pfizer’s PAXLOVID
Mar 16, 2023 03:18PM FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for Pfizer’s PAXLOVID™
Mar 13, 2023 06:45AM Pfizer (PFE) Acquires Seagen (SGEN) for $43B or $229/sh
Mar 13, 2023 06:45AM Pfizer Invests $43 Billion to Battle Cancer
Mar 13, 2023 06:45AM Pfizer Invests $43 Billion to Battle Cancer
Mar 10, 2023 06:45AM Pfizer’s ZAVZPRET™ (zavegepant) Migraine Nasal Spray Receives FDA Approval
Feb 28, 2023 04:40PM Pfizer (PFE) Announces Positive FDA Advisory Committee Votes Supporting Potential Approval for Vaccine Candidate to Help Combat RSV in Older Adults
Feb 28, 2023 04:40PM Pfizer Receives Positive FDA Advisory Committee Votes Supporting Potential Approval for Vaccine Candidate to Help Combat RSV in Older Adults
Feb 27, 2023 10:00AM Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
Feb 22, 2023 06:46AM Pfizer's (PFE) Elranatamab Granted FDA and EMA Filing Acceptance
Feb 22, 2023 06:45AM Pfizer’s Elranatamab Receives FDA and EMA Filing Acceptance
Feb 21, 2023 06:45AM Pfizer (PFE) Announces FDA Acceptance of Application for Respiratory Syncytial Virus Maternal Vaccine Candidate for Priority Review
Feb 21, 2023 06:45AM U.S. FDA Accepts Biologics License Application for Pfizer’s Respiratory Syncytial Virus Maternal Vaccine Candidate for Priority Review
Feb 17, 2023 05:49AM Pfizer (PFE) and Valneva (VALN) Issue Update on Phase 3 Clinical Trial of VLA15
Feb 17, 2023 01:00AM Pfizer and Valneva Issue Update on Phase 3 Clinical Trial Evaluating Lyme Disease Vaccine Candidate VLA15
Feb 16, 2023 06:45AM Pfizer (PFE) Announces Publication of Phase 3 Data for Zavegepant
Feb 16, 2023 06:45AM Pfizer Announces The Lancet Neurology Has Published Phase 3 Data for Zavegepant for the Acute Treatment of Migraine in Adults
Feb 10, 2023 12:09PM Pfizer (PFE) Announces FDA Approves Supplemental New Drug Application for CIBINQO
Feb 10, 2023 12:09PM FDA Approves Pfizer's Supplemental New Drug Application for CIBINQO® (abrocitinib)
Feb 9, 2023 10:00AM Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Jan 17, 2023 06:46AM Pfizer (PFE) Expands ‘An Accord for a Healthier World’ Product Offering
Jan 17, 2023 06:45AM Pfizer Expands ‘An Accord for a Healthier World’ Product Offering to Include Full Portfolio for Greater Benefit to 1.2 Billion People in 45 Lower-Income Countries
Jan 6, 2023 06:47AM Pfizer (PFE) Announces FDA Acceptance for Priority Review of sBLA for 20vPnC
Jan 6, 2023 06:45AM U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine in Infants and Children
Jan 3, 2023 10:00AM Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Dec 29, 2022 06:49AM Pfizer (PFE) Reports Positive Top-Line Results from Phase 3 Study of fidanacogene elaparvovec
Dec 29, 2022 06:45AM Pfizer Announces Positive Top-Line Results from Phase 3 Study of Hemophilia B Gene Therapy Candidate
Dec 28, 2022 06:46AM Pfizer (PFE) Announces FDA Acceptance of BLA for MenABCWY
View More Recent Stories View Older Stories